18 results on '"Holvoet B"'
Search Results
2. High fat diet induces a tumor like metabolism in the liver
- Author
-
Duarte, J., primary, Schmieder, R., additional, Veys, K., additional, Broekaert, D., additional, Napolitano, F., additional, Holvoet, B., additional, Gilis, M., additional, Vriens, K., additional, Garcia, J.F., additional, Grünewald, T., additional, Mathieu, C., additional, Deroose, C., additional, Bernardo, D.D., additional, de Bock, K., additional, and Fendt, S.-M., additional
- Published
- 2018
- Full Text
- View/download PDF
3. In vivo tracking of canine myoblasts mediated by the sodium iodide symporter gene expression
- Author
-
Punzón, I., primary, Mauduit, D., additional, Barthélémy, I., additional, Holvoet, B., additional, Blanchard-Gutton, N., additional, Thibaud, J., additional, de Fornel, P., additional, Deroose, C., additional, Vilquin, J., additional, Sampaolesi, M., additional, and Blot, S., additional
- Published
- 2017
- Full Text
- View/download PDF
4. SAT-123 - High fat diet induces a tumor like metabolism in the liver
- Author
-
Duarte, J., Schmieder, R., Veys, K., Broekaert, D., Napolitano, F., Holvoet, B., Gilis, M., Vriens, K., Garcia, J.F., Grünewald, T., Mathieu, C., Deroose, C., Bernardo, D.D., de Bock, K., and Fendt, S.-M.
- Published
- 2018
- Full Text
- View/download PDF
5. P.306 - In vivo tracking of canine myoblasts mediated by the sodium iodide symporter gene expression
- Author
-
Punzón, I., Mauduit, D., Barthélémy, I., Holvoet, B., Blanchard-Gutton, N., Thibaud, J., de Fornel, P., Deroose, C., Vilquin, J., Sampaolesi, M., and Blot, S.
- Published
- 2017
- Full Text
- View/download PDF
6. Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis
- Author
-
Rebeca Alba Rubio, Shinya Kuroda, Chantal Mathieu, Yasuaki Karasawa, Jos van Pelt, Jia Zeng, Roberta Schmieder, Thomas G. P. Grunewald, Johannes V. Swinnen, Bryan Holvoet, Jonas Dehairs, Masashi Fujii, Roman Vangoitsenhoven, Francesco Napolitano, Diego di Bernardo, James Dooley, Koen Veys, Adrian Liston, Dorien Broekaert, Lindsay A. Broadfield, Juan Fernández-García, Sarah-Maria Fendt, Kim Vriens, Miki Eto, Diether Lambrechts, Joao A.G. Duarte, Katrien De Bock, Suguru Fujita, Christophe Deroose, Mélanie Planque, Joke Van Elsen, Broadfield, L. A., Duarte, J. A. G., Schmieder, R., Broekaert, D., Veys, K., Planque, M., Vriens, K., Karasawa, Y., Napolitano, F., Fujita, S., Fujii, M., Eto, M., Holvoet, B., Vangoitsenhoven, R., Fernandez-Garcia, J., Van Elsen, J., Dehairs, J., Zeng, J., Dooley, J., Rubio, R. A., Van Pelt, J., Grunewald, T. G. P., Liston, A., Mathieu, C., Deroose, C. M., Swinnen, J. V., Lambrechts, D., Di Bernardo, D., Kuroda, S., De Bock, K., and Fendt, S. -M.
- Subjects
0301 basic medicine ,Proteomics ,Cancer Research ,Glucose uptake ,Palmitates ,Palmitate ,Mice ,Random Allocation ,0302 clinical medicine ,Serine ,Hepatocyte ,Dietary Fat ,chemistry.chemical_classification ,Chemistry ,Fatty Acids ,Liver Neoplasms ,3. Good health ,Cell Transformation, Neoplastic ,Oncology ,Liver Neoplasm ,030220 oncology & carcinogenesis ,Pyruvate carboxylase activity ,Liver cancer ,Reactive Oxygen Specie ,Human ,Transcriptional Activation ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Citric Acid Cycle ,Carbohydrate metabolism ,Peroxisome ,Diet, High-Fat ,Article ,03 medical and health sciences ,Internal medicine ,Diabetes mellitus ,medicine ,Peroxisomes ,Animals ,Humans ,Lactic Acid ,Obesity ,Carcinogen ,Pyruvate Carboxylase ,Reactive oxygen species ,Animal ,Proteomic ,Lipid metabolism ,Glucose Tolerance Test ,medicine.disease ,Lipid Metabolism ,Dietary Fats ,Mice, Inbred C57BL ,030104 developmental biology ,Endocrinology ,Glucose ,Hepatocytes ,Reactive Oxygen Species ,Fatty Acid - Abstract
Hepatic fat accumulation is associated with diabetes and hepatocellular carcinoma (HCC). Here, we characterize the metabolic response that high-fat availability elicits in livers before disease development. After a short term on a high-fat diet (HFD), otherwise healthy mice showed elevated hepatic glucose uptake and increased glucose contribution to serine and pyruvate carboxylase activity compared with control diet (CD) mice. This glucose phenotype occurred independently from transcriptional or proteomic programming, which identifies increased peroxisomal and lipid metabolism pathways. HFD-fed mice exhibited increased lactate production when challenged with glucose. Consistently, administration of an oral glucose bolus to healthy individuals revealed a correlation between waist circumference and lactate secretion in a human cohort. In vitro, palmitate exposure stimulated production of reactive oxygen species and subsequent glucose uptake and lactate secretion in hepatocytes and liver cancer cells. Furthermore, HFD enhanced the formation of HCC compared with CD in mice exposed to a hepatic carcinogen. Regardless of the dietary background, all murine tumors showed similar alterations in glucose metabolism to those identified in fat exposed nontransformed mouse livers, however, particular lipid species were elevated in HFD tumor and nontumor-bearing HFD liver tissue. These findings suggest that fat can induce glucose-mediated metabolic changes in nontransformed liver cells similar to those found in HCC. Significance: With obesity-induced hepatocellular carcinoma on a rising trend, this study shows in normal, nontransformed livers that fat induces glucose metabolism similar to an oncogenic transformation.
- Published
- 2021
7. Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis.
- Author
-
Broadfield LA, Duarte JAG, Schmieder R, Broekaert D, Veys K, Planque M, Vriens K, Karasawa Y, Napolitano F, Fujita S, Fujii M, Eto M, Holvoet B, Vangoitsenhoven R, Fernandez-Garcia J, Van Elsen J, Dehairs J, Zeng J, Dooley J, Rubio RA, van Pelt J, Grünewald TGP, Liston A, Mathieu C, Deroose CM, Swinnen JV, Lambrechts D, di Bernardo D, Kuroda S, De Bock K, and Fendt SM
- Subjects
- Animals, Carcinoma, Hepatocellular metabolism, Cell Transformation, Neoplastic, Citric Acid Cycle physiology, Fatty Acids metabolism, Glucose Tolerance Test, Humans, Lactic Acid biosynthesis, Lipid Metabolism, Liver Neoplasms metabolism, Mice, Mice, Inbred C57BL, Obesity complications, Palmitates pharmacology, Peroxisomes metabolism, Proteomics, Pyruvate Carboxylase metabolism, Random Allocation, Reactive Oxygen Species metabolism, Serine metabolism, Transcriptional Activation, Carcinoma, Hepatocellular etiology, Diet, High-Fat, Dietary Fats metabolism, Glucose metabolism, Hepatocytes metabolism, Liver Neoplasms etiology
- Abstract
Hepatic fat accumulation is associated with diabetes and hepatocellular carcinoma (HCC). Here, we characterize the metabolic response that high-fat availability elicits in livers before disease development. After a short term on a high-fat diet (HFD), otherwise healthy mice showed elevated hepatic glucose uptake and increased glucose contribution to serine and pyruvate carboxylase activity compared with control diet (CD) mice. This glucose phenotype occurred independently from transcriptional or proteomic programming, which identifies increased peroxisomal and lipid metabolism pathways. HFD-fed mice exhibited increased lactate production when challenged with glucose. Consistently, administration of an oral glucose bolus to healthy individuals revealed a correlation between waist circumference and lactate secretion in a human cohort. In vitro , palmitate exposure stimulated production of reactive oxygen species and subsequent glucose uptake and lactate secretion in hepatocytes and liver cancer cells. Furthermore, HFD enhanced the formation of HCC compared with CD in mice exposed to a hepatic carcinogen. Regardless of the dietary background, all murine tumors showed similar alterations in glucose metabolism to those identified in fat exposed nontransformed mouse livers, however, particular lipid species were elevated in HFD tumor and nontumor-bearing HFD liver tissue. These findings suggest that fat can induce glucose-mediated metabolic changes in nontransformed liver cells similar to those found in HCC. SIGNIFICANCE: With obesity-induced hepatocellular carcinoma on a rising trend, this study shows in normal, nontransformed livers that fat induces glucose metabolism similar to an oncogenic transformation., (©2021 American Association for Cancer Research.)
- Published
- 2021
- Full Text
- View/download PDF
8. In Vivo Myoblasts Tracking Using the Sodium Iodide Symporter Gene Expression in Dogs.
- Author
-
Punzón I, Mauduit D, Holvoet B, Thibaud JL, de Fornel P, Deroose CM, Blanchard-Gutton N, Vilquin JT, Sampaolesi M, Barthélémy I, and Blot S
- Abstract
Stem cell-based therapies are a promising approach for the treatment of degenerative muscular diseases; however, clinical trials have shown inconclusive and even disappointing results so far. Noninvasive cell monitoring by medicine imaging could improve the understanding of the survival and biodistribution of cells following injection. In this study, we assessed the canine sodium iodide symporter (cNIS) reporter gene as an imaging tool to track by single-photon emission computed tomography (SPECT/CT) transduced canine myoblasts after intramuscular (IM) administrations in dogs. cNIS-expressing cells kept their myogenic capacities and showed strong
99 m Tc-pertechnetate (99 m TcO4 - ) uptake efficiency both in vitro and in vivo . cNIS expression allowed visualization of cells by SPECT/CT along time: 4 h, 48 h, 7 days, and 30 days after IM injection; biopsies collected 30 days post administration showed myofiber's membranes expressing cNIS. This study demonstrates that NIS can be used as a reporter to track cells in vivo in the skeletal muscle of large animals. Our results set a proof of concept of the benefits NIS-tracking tool may bring to the already challenging cell-based therapies arena in myopathies and pave the way to a more efficient translation to the clinical setting from more accurate pre-clinical results., (© 2020 The Authors.)- Published
- 2020
- Full Text
- View/download PDF
9. Noninvasive Monitoring of Suicide Gene Therapy by Using Multimodal Molecular Imaging.
- Author
-
Holvoet B, Leten C, Deroose CM, and Himmelreich U
- Subjects
- Animals, Brain Neoplasms diagnostic imaging, Brain Neoplasms therapy, Disease Models, Animal, Humans, Magnetic Resonance Imaging, Mice, Mice, Nude, Neoplasms therapy, Positron-Emission Tomography, Genes, Transgenic, Suicide, Genetic Therapy methods, Human Embryonic Stem Cells, Molecular Imaging methods, Multimodal Imaging methods, Neoplasms diagnostic imaging
- Abstract
Cells expressing suicide genes can be used as therapeutic vehicles for difficult-to-treat tumors, for example, if stem cells are used that are able to track infiltrating tumor cells. An alternative application of suicide gene expression is their use as a safety switch in regenerative medicine where the presence of a few pluripotent stem cells could potentially cause unwanted side effects like the formation of teratoma. One potential bottleneck of these applications is that information on the initiation of cell suicide is needed early on, for example, when therapeutic cells have reached infiltrating tumor cells or when teratomas are formed. Therefore, in vivo imaging methods are needed that provide information on target location, (stem) cell location, (stem) cell viability, pathology, and suicide gene expression. This requires multimodal imaging approaches that can provide this information longitudinally and in a noninvasive way. Here, we describe examples of how therapeutic cells can be modified so that they express a suicide gene and genes that can be used for in vivo visualization.
- Published
- 2019
- Full Text
- View/download PDF
10. Tri-modal In vivo Imaging of Pancreatic Islets Transplanted Subcutaneously in Mice.
- Author
-
Liang S, Louchami K, Holvoet B, Verbeke R, Deroose CM, Manshian B, Soenen SJ, Lentacker I, and Himmelreich U
- Subjects
- Animals, Cell Line, Female, Humans, Mice, Mice, Nude, Rats, Wistar, Islets of Langerhans diagnostic imaging, Islets of Langerhans Transplantation, Multimodal Imaging methods, Subcutaneous Tissue diagnostic imaging
- Abstract
Purpose: Transplantation of pancreatic islets (PIs) is a promising therapeutic approach for type 1 diabetes. The main obstacle for this strategy is that the outcome of islet engraftment depends on the engraftment site. It was our aim to develop a strategy for using non-invasive imaging techniques to assess the location and fate of transplanted PIs longitudinally in vivo., Procedures: In order to overcome the limitations of individual imaging techniques and cross-validate findings by different modalities, we have combined fluorine magnetic resonance imaging (F-19 MRI), fluorescence imaging (FLI), and bioluminescent imaging (BLI) for studying subcutaneously transplanted PIs and beta cell-like cells (INS-1E cell line) in vivo. We optimized the transduction (using lentiviral vectors) and labeling procedures (using perfluoro crown ether nanoparticles with a fluorescence dye) for PIs and INS-1E cell imaging., Results: The feasibility of using the proposed imaging methods for PI assessment was demonstrated both in vitro and in vivo. Our data suggested that F-19 MRI is suitable for high-resolution localization of transplanted cells and PIs; FLI is essential for confirmation of contrast localization by histology; and BLI is a reliable method to assess cell viability and survival after transplantation. No significant side effects on cell viability and function have been observed., Conclusions: The proposed tri-modal imaging platform is a valuable approach for the assessment of engrafted PIs in vivo. It is potentially suitable for comparing different transplantation sites and evaluating novel strategies for improving PI transplantation technique in the future.
- Published
- 2018
- Full Text
- View/download PDF
11. A Multimodal Imaging Approach Enables In Vivo Assessment of Antifungal Treatment in a Mouse Model of Invasive Pulmonary Aspergillosis.
- Author
-
Poelmans J, Himmelreich U, Vanherp L, Zhai L, Hillen A, Holvoet B, Belderbos S, Brock M, Maertens J, Vande Velde G, and Lagrou K
- Subjects
- Animals, Disease Models, Animal, Disease Progression, Leukopenia immunology, Luminescent Measurements, Lung microbiology, Lung pathology, Magnetic Resonance Imaging, Male, Mice, Mice, Inbred BALB C, Multimodal Imaging methods, Treatment Outcome, Antifungal Agents therapeutic use, Aspergillus fumigatus drug effects, Invasive Pulmonary Aspergillosis diagnostic imaging, Invasive Pulmonary Aspergillosis drug therapy, Voriconazole therapeutic use
- Abstract
Aspergillus fumigatus causes life-threatening lung infections in immunocompromised patients. Mouse models are extensively used in research to assess the in vivo efficacies of antifungals. In recent years, there has been an increasing interest in the use of noninvasive imaging techniques to evaluate experimental infections. However, single imaging modalities have limitations concerning the type of information they can provide. In this study, magnetic resonance imaging and bioluminescence imaging were combined to obtain longitudinal information on the extent of developing lesions and fungal load in a leukopenic mouse model of invasive pulmonary aspergillosis (IPA). This multimodal imaging approach was used to assess changes occurring within lungs of infected mice receiving voriconazole treatment starting at different time points after infection. The results showed that IPA development depends on the inoculum size used to infect animals and that disease can be successfully prevented or treated by initiating intervention during early stages of infection. Furthermore, we demonstrated that a reduction in fungal load is not necessarily associated with the disappearance of lesions on anatomical lung images, especially when antifungal treatment coincides with immune recovery. In conclusion, multimodal imaging allows an investigation of different aspects of disease progression or recovery by providing complementary information on dynamic processes, which are highly useful for assessing the efficacy of (novel) therapeutic compounds in a time- and labor-efficient manner., (Copyright © 2018 American Society for Microbiology.)
- Published
- 2018
- Full Text
- View/download PDF
12. The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction.
- Author
-
Neyrinck K, Breuls N, Holvoet B, Oosterlinck W, Wolfs E, Vanbilloen H, Gheysens O, Duelen R, Gsell W, Lambrichts I, Himmelreich U, Verfaillie CM, Sampaolesi M, and Deroose CM
- Subjects
- Animals, Cell Line, Female, Genes, Reporter, Human Embryonic Stem Cells cytology, Human Embryonic Stem Cells metabolism, Humans, Luciferases genetics, Luciferases metabolism, Mice, Mice, Nude, Myocardial Infarction diagnostic imaging, Myocytes, Cardiac cytology, Myocytes, Cardiac metabolism, Octreotide analogs & derivatives, Organometallic Compounds, Positron-Emission Tomography, Radiopharmaceuticals, Receptors, Somatostatin genetics, Stem Cell Transplantation adverse effects, Teratoma etiology, Human Embryonic Stem Cells transplantation, Myocardial Infarction therapy, Receptors, Somatostatin metabolism, Stem Cell Transplantation methods, Teratoma diagnostic imaging
- Abstract
Rationale: Pluripotent stem cells (PSCs) are being investigated as a cell source for regenerative medicine since they provide an infinitive pool of cells that are able to differentiate towards every cell type of the body. One possible therapeutic application involves the use of these cells to treat myocardial infarction (MI), a condition where billions of cardiomyocytes (CMs) are lost. Although several protocols have been developed to differentiate PSCs towards CMs, none of these provide a completely pure population, thereby still posing a risk for neoplastic teratoma formation. Therefore, we developed a strategy to (i) monitor cell behavior noninvasively via site-specific integration of firefly luciferase (Fluc) and the human positron emission tomography (PET) imaging reporter genes, sodium iodide symporter (hNIS) and somatostatin receptor type 2 (hSSTr2), and (ii) perform hSSTr2-mediated suicide gene therapy via the clinically used radiopharmacon
177 Lu-DOTATATE. Methods: Human embryonic stem cells (ESCs) were gene-edited via zinc finger nucleases to express Fluc and either hNIS or hSSTr2 in the safe harbor locus, adeno-associated virus integration site 1. Firstly, these cells were exposed to 4.8 MBq177 Lu-DOTATATE in vitro and cell survival was monitored via bioluminescence imaging (BLI). Afterwards, hNIS+ and hSSTr2+ ESCs were transplanted subcutaneously and teratomas were allowed to form. At day 59, baseline124 I and68 Ga-DOTATATE PET and BLI scans were performed. The day after, animals received either saline or 55 MBq177 Lu-DOTATATE. Weekly BLI scans were performed, accompanied by124 I and68 Ga-DOTATATE PET scans at days 87 and 88, respectively. Finally, hSSTr2+ ESCs were differentiated towards CMs and transplanted intramyocardially in the border zone of an infarct that was induced by left anterior descending coronary artery ligation. After transplantation, the animals were monitored via BLI and PET, while global cardiac function was evaluated using cardiac magnetic resonance imaging. Results: Teratoma growth of both hNIS+ and hSSTr2+ ESCs could be followed noninvasively over time by both PET and BLI. After177 Lu-DOTATATE administration, successful cell killing of the hSSTr2+ ESCs was achieved both in vitro and in vivo , indicated by reductions in total tracer lesion uptake, BLI signal and teratoma volume. As undifferentiated hSSTr2+ ESCs are not therapeutically relevant, they were differentiated towards CMs and injected in immune-deficient mice with a MI. Long-term cell survival could be monitored without uncontrolled cell proliferation. However, no improvement in the left ventricular ejection fraction was observed. Conclusion: We developed isogenic hSSTr2-expressing ESCs that allow noninvasive cell monitoring in the context of PSC-derived regenerative therapy. Furthermore, we are the first to use the hSSTr2 not only as an imaging reporter gene, but also as a suicide mechanism for radionuclide therapy in the setting of PSC-derived cell treatment., Competing Interests: Competing interests: Katrien Neyrinck works as an aspirant for the FWO, while both Natacha Breuls and Bryan Holvoet work under an SB-grant of the FWO. Christophe M. Deroose is a consultant for Advanced Accelerator Applications (AAA) and Novartis, who hold rights to commercialize 177Lu-DOTATATE. He is also a consultant for Sirtex, Bayer, Ipsen and Terumo. He received travel grants from GE Healthcare. No other potential conflict of interest relevant to this article was reported.- Published
- 2018
- Full Text
- View/download PDF
13. MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors.
- Author
-
Giacomazzi G, Holvoet B, Trenson S, Caluwé E, Kravic B, Grosemans H, Cortés-Calabuig Á, Deroose CM, Huylebroeck D, Hashemolhosseini S, Janssens S, McNally E, Quattrocelli M, and Sampaolesi M
- Subjects
- Animals, Cell Differentiation, Echocardiography, Heart diagnostic imaging, Humans, Mice, Muscle, Skeletal cytology, Muscle, Skeletal diagnostic imaging, Muscle, Skeletal pathology, Muscular Dystrophy, Animal diagnostic imaging, Myocardium pathology, Regeneration, Heart growth & development, Induced Pluripotent Stem Cells cytology, Mesoderm cytology, MicroRNAs genetics, Muscle Development genetics, Muscle, Skeletal growth & development, Muscular Dystrophy, Animal pathology, Myocardium cytology
- Abstract
Muscular dystrophies (MDs) are often characterized by impairment of both skeletal and cardiac muscle. Regenerative strategies for both compartments therefore constitute a therapeutic avenue. Mesodermal iPSC-derived progenitors (MiPs) can regenerate both striated muscle types simultaneously in mice. Importantly, MiP myogenic propensity is influenced by somatic lineage retention. However, it is still unknown whether human MiPs have in vivo potential. Furthermore, methods to enhance the intrinsic myogenic properties of MiPs are likely needed, given the scope and need to correct large amounts of muscle in the MDs. Here, we document that human MiPs can successfully engraft into the skeletal muscle and hearts of dystrophic mice. Utilizing non-invasive live imaging and selectively induced apoptosis, we report evidence of striated muscle regeneration in vivo in mice by human MiPs. Finally, combining RNA-seq and miRNA-seq data, we define miRNA cocktails that promote the myogenic potential of human MiPs.
- Published
- 2017
- Full Text
- View/download PDF
14. Molecular Imaging of Human Embryonic Stem Cells Stably Expressing Human PET Reporter Genes After Zinc Finger Nuclease-Mediated Genome Editing.
- Author
-
Wolfs E, Holvoet B, Ordovas L, Breuls N, Helsen N, Schönberger M, Raitano S, Struys T, Vanbilloen B, Casteels C, Sampaolesi M, Van Laere K, Lambrichts I, Verfaillie CM, and Deroose CM
- Subjects
- Animals, Cell Differentiation, Cell Line, Endoribonucleases chemistry, Female, Gene Expression, Humans, Liver cytology, Mice, Embryonic Stem Cells metabolism, Endoribonucleases metabolism, Gene Editing, Genes, Reporter genetics, Genome, Human genetics, Positron-Emission Tomography, Zinc Fingers
- Abstract
Molecular imaging is indispensable for determining the fate and persistence of engrafted stem cells. Standard strategies for transgene induction involve the use of viral vectors prone to silencing and insertional mutagenesis or the use of nonhuman genes. Methods: We used zinc finger nucleases to induce stable expression of human imaging reporter genes into the safe-harbor locus adeno-associated virus integration site 1 in human embryonic stem cells. Plasmids were generated carrying reporter genes for fluorescence, bioluminescence imaging, and human PET reporter genes. Results: In vitro assays confirmed their functionality, and embryonic stem cells retained differentiation capacity. Teratoma formation assays were performed, and tumors were imaged over time with PET and bioluminescence imaging. Conclusion: This study demonstrates the application of genome editing for targeted integration of human imaging reporter genes in human embryonic stem cells for long-term molecular imaging., (© 2017 by the Society of Nuclear Medicine and Molecular Imaging.)
- Published
- 2017
- Full Text
- View/download PDF
15. Multipotent adult progenitor cells improve the hematopoietic function in myelodysplasia.
- Author
-
Roobrouck VD, Wolfs E, Delforge M, Broekaert D, Chakraborty S, Sels K, Vanwelden T, Holvoet B, Lhoest L, Khurana S, Pandey S, Hoornaert C, Ponsaerts P, Struys T, Boeckx N, Vandenberghe P, Deroose CM, and Verfaillie CM
- Subjects
- Adult, Animals, Bone Marrow Cells cytology, Cell Differentiation, Female, Hematopoiesis, Humans, In Situ Hybridization, Fluorescence, Mice, Inbred C57BL, Multipotent Stem Cells transplantation, Myelodysplastic Syndromes therapy
- Abstract
Background Aims: Myelodysplastic syndromes (MDS) are a group of clonal stem cell disorders affecting the normal hematopoietic differentiation process and leading to abnormal maturation and differentiation of all blood cell lineages. Treatment options are limited, and there is an unmet medical need for effective therapies for patients with severe cytopenias., Methods: We demonstrate that multipotent adult progenitor cells (MAPC) improve the function of hematopoietic progenitors derived from human MDS bone marrow (BM) by significantly increasing the frequency of primitive progenitors as well as the number of myeloid colonies., Results: This effect was more pronounced in a non-contact culture, indicating the importance of soluble factors produced by the MAPC cells. Moreover, the cells did not stimulate the growth of the abnormal MDS clone, as shown by fluorescent in situ hybridization analysis on BM cells from patients with a known genetic abnormality. We also demonstrate that MAPC cells can provide stromal support for patient-derived hematopoietic cells. When MAPC cells were intravenously injected into a mouse model of MDS, they migrated to the site of injury and increased the hematopoietic function in diseased mice., Discussion: The preclinical studies undertaken here indicate an initial proof of concept for the use of MAPC cell therapy in patients with MDS-related severe and symptomatic cytopenias and should pave the way for further investigation in clinical trials., (Copyright © 2017. Published by Elsevier Inc.)
- Published
- 2017
- Full Text
- View/download PDF
16. Increased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell Imaging.
- Author
-
Holvoet B, De Waele L, Quattrocelli M, Gheysens O, Sampaolesi M, Verfaillie CM, and Deroose CM
- Abstract
Numerous neurodegenerative and neuromuscular disorders are associated with cell-specific depletion in the human body. This imbalance in tissue homeostasis is in healthy individuals repaired by the presence of endogenous stem cells that can replace the lost cell type. However, in most disorders, a genetic origin or limited presence or exhaustion of stem cells impairs correct cell replacement. During the last 30 years, methods to readily isolate and expand stem cells have been developed and this resulted in a major change in the regenerative medicine field as it generates sufficient amount of cells for human transplantation applications. Furthermore, stem cells have been shown to release cytokines with beneficial effects for several diseases. At present however, clinical stem cell transplantations studies are struggling to demonstrate clinical efficacy despite promising preclinical results. Therefore, to allow stem cell therapy to achieve its full potential, more insight in their in vivo behavior has to be achieved. Different methods to noninvasively monitor these cells have been developed and are discussed. In some cases, stem cell monitoring even reached the clinical setting. We anticipate that by further exploring these imaging possibilities and unraveling their in vivo behavior further improvement in stem cell transplantations will be achieved.
- Published
- 2016
- Full Text
- View/download PDF
17. Sodium Iodide Symporter PET and BLI Noninvasively Reveal Mesoangioblast Survival in Dystrophic Mice.
- Author
-
Holvoet B, Quattrocelli M, Belderbos S, Pollaris L, Wolfs E, Gheysens O, Gijsbers R, Vanoirbeek J, Verfaillie CM, Sampaolesi M, and Deroose CM
- Subjects
- Animals, Cell Line, Cell Survival, Cyclosporine therapeutic use, Genes, Reporter, Humans, Immunosuppressive Agents therapeutic use, Luciferases, Firefly analysis, Luciferases, Firefly genetics, Luminescent Measurements, Mice, Inbred C57BL, Mice, Nude, Muscular Dystrophy, Animal diagnosis, Muscular Dystrophy, Animal pathology, Optical Imaging, Symporters genetics, Transduction, Genetic, Blood Vessels cytology, Muscle Development, Muscular Dystrophy, Animal therapy, Positron-Emission Tomography methods, Stem Cell Transplantation, Stem Cells cytology, Symporters analysis
- Abstract
Muscular dystrophies are a heterogeneous group of myopathies, characterized by muscle weakness and degeneration, without curative treatment. Mesoangioblasts (MABs) have been proposed as a potential regenerative therapy. To improve our understanding of the in vivo behavior of MABs and the effect of different immunosuppressive therapies, like cyclosporine A or co-stimulation-adhesion blockade therapy, on cell survival noninvasive cell monitoring is required. Therefore, cells were transduced with a lentiviral vector encoding firefly luciferase (Fluc) and the human sodium iodide transporter (hNIS) to allow cell monitoring via bioluminescence imaging (BLI) and small-animal positron emission tomography (PET). Non-H2 matched mMABs were injected in the femoral artery of dystrophic mice and were clearly visible via small-animal PET and BLI. Based on noninvasive imaging data, we were able to show that co-stim was clearly superior to CsA in reducing cell rejection and this was mediated via a reduction in cytotoxic T cells and upregulation of regulatory T cells., (Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
18. Optimization of multimodal imaging of mesenchymal stem cells using the human sodium iodide symporter for PET and Cerenkov luminescence imaging.
- Author
-
Wolfs E, Holvoet B, Gijsbers R, Casteels C, Roberts SJ, Struys T, Maris M, Ibrahimi A, Debyser Z, Van Laere K, Verfaillie CM, and Deroose CM
- Subjects
- Animals, Cell Differentiation drug effects, Genes, Reporter genetics, Genetic Vectors genetics, HEK293 Cells, Humans, Iodine Radioisotopes, Lentivirus genetics, Mesenchymal Stem Cells cytology, Mesenchymal Stem Cells drug effects, Mice, Peptide Elongation Factor 1 genetics, Puromycin pharmacology, Luminescence, Mesenchymal Stem Cells metabolism, Multimodal Imaging methods, Optical Imaging methods, Positron-Emission Tomography methods, Symporters genetics
- Abstract
Purpose: The use of stably integrated reporter gene imaging provides a manner to monitor the in vivo fate of engrafted cells over time in a non-invasive manner. Here, we optimized multimodal imaging (small-animal PET, Cerenkov luminescence imaging (CLI) and bioluminescence imaging (BLI)) of mesenchymal stem cells (MSCs), by means of the human sodium iodide symporter (hNIS) and firefly luciferase (Fluc) as reporters., Methods: First, two multicistronic lentiviral vectors (LV) were generated for multimodal imaging: BLI, 124I PET/SPECT and CLI. Expression of the imaging reporter genes was validated in vitro using 99mTcO4- radioligand uptake experiments and BLI. Uptake kinetics, specificity and tracer elution were determined as well as the effect of the transduction process on the cell's differentiation capacity. MSCs expressing the LV were injected intravenously or subcutaneously and imaged using small-animal PET, CLI and BLI., Results: The expression of both imaging reporter genes was functional and specific. An elution of 99mTcO4- from the cells was observed, with 31% retention after 3 h. After labeling cells with 124I in vitro, a significantly higher CLI signal was noted in hNIS expressing murine MSCs. Furthermore, it was possible to visualize cells injected intravenously using BLI or subcutaneously in mice, using 124I small-animal PET, CLI and BLI., Conclusions: This study identifies hNIS as a suitable reporter gene for molecular imaging with PET and CLI, as confirmed with BLI through the expression of Fluc. It supports the potential for a wider application of hNIS reporter gene imaging and future clinical applications.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.